EyePoint Pharmaceuticals
EYPT
EYPT
49 hedge funds and large institutions have $33.9M invested in EyePoint Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 5 closing their positions.
Holders
49
Holders Change
+4
Holders Change %
+8.89%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
16
Reduced
13
Closed
5
Calls
$248K
Puts
$193K
Net Calls
+$55K
Net Calls Change
-$118K
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$5.89M |
| 2 |
2
Renaissance Technologies
New York
|
$2.87M |
| 3 |
3
Millennium Management
New York
|
$589K |
| 4 |
PA
4
Perceptive Advisors
New York
|
$2M |
| 5 |
5
Two Sigma Investments
New York
|
$366K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | – | -290 | Closed |
|
|
LTFS
52
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | – | -50 | Closed |
|
53
UBS Group
Zurich,
Switzerland
| – | – | -39 | Closed |
|
54
Simplex Trading
Chicago,
Illinois
| – | – | -10 | Closed |
|
|
SM
55
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|